Medicare Enrolled

Dr. Everett Allen, MD

Rheumatology · San Antonio, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
19272 STONE OAK PKWY, San Antonio, TX 78258
2102658851
In practice since 2006 (20 years)
NPI: 1609846641 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Allen from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Allen? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Allen

Dr. Everett Allen is a rheumatology in San Antonio, TX, with 20 years in practice. Based on federal Medicare data, Dr. Allen performed 148,871 Medicare services across 4,176 unique beneficiaries.

Between the years covered by Open Payments, Dr. Allen received a total of $24,207 from 51 pharmaceutical and/or device companies across 1154 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Allen is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 8% volume in TX$ $24,207 industry payments

Medicare Practice Summary

Medicare Utilization ↗
148,871
Medicare services
Top 8% in TX for rheumatology
4,176
Unique beneficiaries
$15
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~7,444 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Golimumab infusion (Simponi Aria)36,750$10$48
Certolizumab injection (Cimzia)36,000$4$19
Abatacept infusion (Orencia)26,025$34$134
Tocilizumab injection (Actemra)13,760$5$17
Romosozumab injection (Evenity) for osteoporosis12,810$8$28
Denosumab injection (Prolia/Xgeva)4,380$18$42
Infliximab infusion (Remicade)4,132$26$114
Injection, rituximab, 10 mg2,461$60$257
Injection, infliximab-abda, biosimilar, (renflexis), 10 mg2,340$31$119
Joint lubricant injection (Synvisc)1,488$7$25
Office visit, established patient (30-39 min)1,093$87$253
Comprehensive metabolic blood panel977$10$26
Complete blood count (CBC) with differential902$8$20
C-reactive protein test (inflammation marker)834$5$14
Measurement of antibody for assessment of autoimmune disorder, any method812$17$44
Administration of chemotherapy into vein, 1 hour or less792$100$399
Sed rate test (inflammation marker)613$3$6
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle368$55$222
Administration of chemotherapy into vein, each additional hour208$21$85
Measurement of complement (immune system proteins), antigen,206$11$29
Measurement of dna antibody, native or double stranded179$13$35
Measurement of dna antibody, single stranded175$11$29
Analysis of substance using immunoassay technique, multiple step method174$11$28
Injection, methylprednisolone acetate, 40 mg128$6$15
Aspiration and/or injection of fluid large joint using ultrasound guidance122$90$291
New patient office visit (45-59 min)105$116$497
Measurement of antibody for rheumatoid arthritis assessment90$13$32
Rheumatoid factor level88$5$15
Vitamin D level test79$28$72
Injection of additional new drug or substance into vein79$12$47
Uric acid level test74$4$12
Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose74$97$311
Office visit, established patient, complex (40-54 min)64$126$331
Injection, methylprednisolone acetate, 20 mg56$3$4
Cardiolipin antibody (tissue antibody) measurement54$25$63
Injection, methylprednisolone sodium succinate, up to 40 mg53$3$13
Beta 2 glycoprotein 1 antibody (autoantibody) measurement36$25$63
Injection, methylprednisolone sodium succinate, up to 125 mg33$4$18
Flu vaccine, quadrivalent27$73$75
Flu vaccine administration27$30$61
Creatine kinase (cardiac enzyme) level, total26$6$17
Vitamin B-12 level test22$15$38
Aspiration and/or injection of fluid from small joint20$34$96
Office visit, established patient (20-29 min)20$56$166
Ferritin level test (iron stores)19$13$35
Iron binding capacity test18$9$22
New patient office visit, complex (60-74 min)18$152$453
Thyroid stimulating hormone (TSH) test17$16$42
Injection into tendon or ligament16$44$116
Joint injection, major joint16$50$133
Liver function blood test panel11$8$20
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
44.9% high complexity
50.5% medium
4.5% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$24,207
Total received (2018-2024)
Avg $3,458/year across 7 years
Top 17% in TX for rheumatology
51
Companies
1,154
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$24,049 (99.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$158 (0.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,621
2023
$3,906
2022
$3,331
2021
$2,651
2020
$2,059
2019
$4,200
2018
$4,439

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$3,867
Novartis Pharmaceuticals Corporation
$1,782
UCB, Inc.
$1,753
Lilly USA, LLC
$1,438
Janssen Biotech, Inc.
$1,434
Mallinckrodt Hospital Products Inc.
$1,389
GlaxoSmithKline, LLC.
$1,324
Horizon Therapeutics plc
$1,278
E.R. Squibb & Sons, L.L.C.
$1,257
PFIZER INC.
$1,088
GENZYME CORPORATION
$1,012
Genentech USA, Inc.
$767
Radius Health, Inc.
$742
Flexion Therapeutics, Inc.
$734
Aurinia Pharma U.S., Inc.
$589
Ferring Pharmaceuticals Inc.
$371
Horizon Pharma plc
$331
Actelion Pharmaceuticals US, Inc.
$292
Celgene Corporation
$255
AstraZeneca Pharmaceuticals LP
$240
SANOFI-AVENTIS U.S. LLC
$227
AbbVie, Inc.
$215
Merck Sharp & Dohme Corporation
$213
ANI Pharmaceuticals, Inc.
$190
Pacira Therapeutics, Inc.
$172
Johnson & Johnson Health Care Systems Inc.
$150
Fresenius Kabi USA, LLC
$118
Boehringer Ingelheim Pharmaceuticals, Inc.
$111
Hikma Pharmaceuticals USA
$100
Antares Pharma, Inc.
$98
Ironwood Pharmaceuticals, Inc
$71
Mallinckrodt Enterprises LLC
$64
Exeltis, USA Inc.
$64
Takeda Pharmaceuticals U.S.A., Inc.
$55
Teva Pharmaceuticals USA, Inc.
$46
ABBVIE INC.
$43
Organon LLC
$43
Nevro Corp.
$31
Bayer HealthCare Pharmaceuticals Inc.
$30
SCILEX PHARMACEUTICALS INC.
$29
Bioventus LLC
$29
MEDEXUS PHARMA, INC.
$23
Ultragenyx Pharmaceutical Inc.
$22
Octapharma USA, Inc.
$20
FIDIA PHARMA USA INC.
$17
Sandoz Inc.
$16
Sebela Pharmaceuticals Inc.
$15
Merck Sharp & Dohme LLC
$14
Endo Pharmaceuticals Inc.
$13
SHIELD THERAPEUTICS INC
$13
MEDAC PHARMA, INC.
$11
Top 3 companies account for 30.6% of total payments
Associated products mentioned in payments ›
ACCRUFER · ACTHAR · AMJEVITA · AREXVY · AVSOLA · Actemra · Adempas · BELSOMRA · BENLYSTA · BEXSERO · Bimzelx · COBENFY · COSENTYX · CUVITRU · CYLTEZO · Cimzia · DUZALLO · Durolane · EMBEDA · EUFLEXXA · EVENITY · Enbrel · FORTEO · HADLIMA · HYRIMOZ · Humira · Hymovis · IDACIO · INFLECTRA · KEVZARA · KRYSTEXXA · LUPKYNIS · LYRICA · Mitigare · NASCOBAL · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · ONTRUZANT · OPSUMIT · ORENCIA · OTREXUP · Otezla · Otrexup · PENNSAID · PNEUMOVAX 23 · PREVNAR 13 · PREVNAR 20 · PURIFIED CORTROPHIN GEL · Prolia · RAYOS · REMICADE · RENFLEXIS · RHEUMATOID ARTHRITIS DISEASE · RIDAURA · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SHINGRIX · SIMLANDI · SIMPONI · SIMPONI ARIA · SYNVISC-ONE · Senza · TALTZ · TAVNEOS · TRELEGY ELLIPTA · TREMFYA · Tavneos · Tymlos · UPTRAVI · Uloric · XELJANZ · ZTLido · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $16 per 100 Medicare services performed
Looking for a rheumatology in San Antonio?
Compare rheumatologys in the San Antonio area by procedure volume, costs, and industry payment transparency.
Browse rheumatologys nearby

Geographic Context

Rheumatologys within 10 mi
50
Per 100K population
2.5
County median income
$70,571
Nearest hospital
SOUTH TEXAS SPINE AND SURGICAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Allen is a mixed practice specialist, with above-average Medicare volume (top 8% in TX), and high industry engagement (low-engagement, top 17%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Allen experienced with golimumab infusion (simponi aria)?
Based on Medicare claims data, Dr. Allen performed 36,750 golimumab infusion (simponi aria) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Allen receive payments from pharmaceutical companies?
Yes. Dr. Allen received a total of $24,207 from 51 companies across 1,154 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Allen's costs compare to other rheumatologys in San Antonio?
Dr. Allen's average Medicare payment per service is $15. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Allen) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →